David V. Weinberg, MD

Publications

• Self-reporting of Conflicts of Interest by Ophthalmology Researchers Compared with the Open Payments Database Industry Reports.

  (Hwang ES, Liu L, Ong MY, Rodriguez CM, Schwehr DE, Sanchez DE, Stoddard GJ, Weinberg DV.) Ophthalmology. 2022 Nov 01 PMID: 36332841 SCOPUS ID: 2-s2.0-85145331595 11/05/2022

• Compound heterozygous splicing CDON variants result in isolated ocular coloboma.

  (Reis LM, Basel D, McCarrier J, Weinberg DV, Semina EV.) Clin Genet. 2020 Nov;98(5):486-492 PMID: 32729136 PMCID: PMC8341436 SCOPUS ID: 2-s2.0-85089451171 07/31/2020

• Accuracy of Spectral-Domain OCT of the Macula for Detection of Complete Posterior Vitreous Detachment.

  (Hwang ES, Kraker JA, Griffin KJ, Sebag J, Weinberg DV, Kim JE.) Ophthalmol Retina. 2020 Feb;4(2):148-153 PMID: 31864940 PMCID: PMC7008078 SCOPUS ID: 2-s2.0-85077163728 12/23/2019

• Edema within Epiretinal Proliferation in a Diabetic Patient.

  (Mandviwala MM, Weinberg DV, Hwang ES.) Ophthalmology. 2019 Sep;126(9):1272 PMID: 31443788 SCOPUS ID: 2-s2.0-85070675648 08/25/2019

• An innovative visual acuity chart for urgent and primary care settings: validation of the Runge near vision card.

  (Cooke MD, Winter PA, McKenney KC, Packard KL, Williams V, Dorsey EA, Szabo A, Visotcky A, Warren CC, Wirostko WJ, Weinberg DV, Kim JE, Han DP.) Eye (Lond). 2019 Jul;33(7):1104-1110 PMID: 30792525 PMCID: PMC6707193 SCOPUS ID: 2-s2.0-85068856000 02/23/2019

• Assessment of Consistency Between Peer-Reviewed Publications and Clinical Trial Registries.

  (Sun LW, Lee DJ, Collins JA, Carll TC, Ramahi K, Sandy SJ, Unteriner JG, Weinberg DV.) JAMA Ophthalmol. 2019 May 01;137(5):552-556 PMID: 30946427 PMCID: PMC6512264 SCOPUS ID: 2-s2.0-85063992673 04/05/2019

• Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.

  (Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY, Age-Related Eye Disease Study 2 Research Group.) Ophthalmology. 2019 Feb;126(2):261-273 PMID: 30142373 PMCID: PMC6348044 SCOPUS ID: 2-s2.0-85053693825 08/25/2018

• Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2

  (Pauleikhoff D, Bonelli R, Dubis AM, Gunnemann F, Rothaus K, Charbel Issa P, Heeren TFC, Peto T, Clemons TE, Chew EY, Bird AC, Sallo FB, Bakri S, Bernstein PS, Blodi B, Brucker A, Bucher F, Chung M, Comer G, Constable I, Cooney M, Do D, Duncan J, Egan C, Elman MJ, Fawzi A, Friedlander M, Gaudric A, Gillies MC, Goldberg R, Googe JM, Guymer R, Higgins P, Holz F, Houghton O, Hoyng CB, Hubschman JP, Jhaveri C, Khanani A, Lally D, Lee C, Lee M, Miller JW, Miller D, Moisseiev J, Murphy R, Narayanan R, Randhawa S, Raphaelian PV, Rich R, Rosen R, Rosenfeld P, Ruys J, Sahel JA, Schwartz S, Singerman L, Sneed S, Soubrane G, Vingerling JR, Warrow D, Weinberg D, Wolf S, Wykoff C, Yan J, Yannuzzi LA, Zhuk SA.) Acta Ophthalmologica. 1 November 2019;97(7):e998-e1005 SCOPUS ID: 2-s2.0-85064150218 11/01/2019

• Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.

  (Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY, AREDS2 Research Group.) Ophthalmology. 2018 Dec;125(12):1913-1928 PMID: 30060980 PMCID: PMC6246813 SCOPUS ID: 2-s2.0-85050484301 08/01/2018

• Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.

  (Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC, Diabetic Retinopathy Clinical Research Network.) Ophthalmology. 2018 Jul;125(7):1054-1063 PMID: 29525602 PMCID: PMC6568257 SCOPUS ID: 2-s2.0-85042941882 03/12/2018

• Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial.

  (Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Altaweel M, Berinstein DM, SCORE2 Investigator Group.) JAMA Ophthalmol. 2018 Apr 01;136(4):337-345 PMID: 29476687 PMCID: PMC5876862 SCOPUS ID: 2-s2.0-85045540809 02/25/2018

• CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

  (Leung I, Sallo FB, Bonelli R, Clemons TE, Pauleikhoff D, Chew EY, Bird AC, Peto T, MacTel Study Group.) Retina. 2018 Jan;38 Suppl 1(Suppl 1):S43-S50 PMID: 29095354 PMCID: PMC5726940 SCOPUS ID: 2-s2.0-85042614696 11/03/2017